Adverum Biotechnologies, Inc. - ADVM
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Dec 09, 2025 | SCHEDULE 13D/A | — | — | — | View |
| Dec 09, 2025 | SCHEDULE 13G/A | Frazier Life Sciences Public Fund, L.P. | 0.0% | 0 | View |
| Dec 09, 2025 | SCHEDULE 13G/A | FHMLSP, L.P. | 0.0% | 0 | View |
| Dec 09, 2025 | SCHEDULE 13G/A | FHMLSP, L.L.C. | 0.0% | 0 | View |
| Dec 09, 2025 | SCHEDULE 13G/A | Frazier Life Sciences X, L.P. | 0.0% | 0 | View |
| Dec 09, 2025 | SCHEDULE 13G/A | FHMLS X, L.P. | 0.0% | 0 | View |
| Dec 09, 2025 | SCHEDULE 13G/A | FHMLS X, L.L.C. | 0.0% | 0 | View |
| Dec 09, 2025 | SCHEDULE 13G/A | Frazier Life Sciences XI, L.P. | 0.0% | 0 | View |
| Dec 09, 2025 | SCHEDULE 13G/A | FHMLS XI, L.P. | 0.0% | 0 | View |
| Dec 09, 2025 | SCHEDULE 13G/A | FHMLS XI, L.L.C. | 0.0% | 0 | View |
| Dec 09, 2025 | SCHEDULE 13G/A | Frazier Life Sciences XII, L.P. | 0.0% | 0 | View |
| Dec 09, 2025 | SCHEDULE 13G/A | FHMLS XII, L.P. | 0.0% | 0 | View |
| Dec 09, 2025 | SCHEDULE 13G/A | FHMLS XII, L.L.C. | 0.0% | 0 | View |
| Dec 09, 2025 | SCHEDULE 13G/A | James N. Topper | 0.0% | 0 | View |
| Dec 09, 2025 | SCHEDULE 13G/A | Patrick J. Heron | 0.0% | 0 | View |
| Dec 05, 2025 | SCHEDULE 13D/A | — | 8.9% | — | View |
| Nov 28, 2025 | SCHEDULE 13G/A | Frazier Life Sciences Public Fund, L.P. | 19.4% | 4,288,949 | View |
| Nov 28, 2025 | SCHEDULE 13G/A | FHMLSP, L.P. | 19.4% | 4,288,949 | View |
| Nov 28, 2025 | SCHEDULE 13G/A | FHMLSP, L.L.C. | 19.4% | 4,288,949 | View |
| Nov 28, 2025 | SCHEDULE 13G/A | Frazier Life Sciences X, L.P. | 1.0% | 216,964 | View |
| Nov 28, 2025 | SCHEDULE 13G/A | FHMLS X, L.P. | 1.0% | 216,964 | View |
| Nov 28, 2025 | SCHEDULE 13G/A | FHMLS X, L.L.C. | 1.0% | 216,964 | View |
| Nov 28, 2025 | SCHEDULE 13G/A | Frazier Life Sciences XI, L.P. | 2.3% | 504,849 | View |
| Nov 28, 2025 | SCHEDULE 13G/A | FHMLS XI, L.P. | 2.3% | 504,849 | View |
| Nov 28, 2025 | SCHEDULE 13G/A | FHMLS XI, L.L.C. | 2.3% | 504,849 | View |
| Nov 28, 2025 | SCHEDULE 13G/A | Frazier Life Sciences XII, L.P. | 2.4% | 522,768 | View |
| Nov 28, 2025 | SCHEDULE 13G/A | FHMLS XII, L.P. | 2.4% | 522,768 | View |
| Nov 28, 2025 | SCHEDULE 13G/A | FHMLS XII, L.L.C. | 2.4% | 522,768 | View |
| Nov 28, 2025 | SCHEDULE 13G/A | James N. Topper | 1.0% | 216,964 | View |
| Nov 28, 2025 | SCHEDULE 13G/A | Patrick J. Heron | 1.0% | 216,964 | View |
| Nov 10, 2025 | SCHEDULE 13D/A | — | 14.6% | — | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.